Synjardy 5 mg/850 mg film-coated tablets
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Synjardy 5 mg/850 mg film-coated tablets, covering 2025-04-16 to 2025-04-16. Get the full timeline:
Most recent: Clinical Trial Update: Pharmacokinetics and Bioequivalence Study of Empagliflozin+Metformin Hydrochloride 5 mg/850 mg Film-coated Tablets (Gedeon Richter Plc., Hungary) Versus Synjardy® 5 mg/850 mg Film-coated Tablets (Boehringer Ingelheim International GmbH, Germany) [Phase 1]